Actively Recruiting
Study of Immune and Pathological Differences in ICU Patients with Influenza and Non-Influenza Severe Community-Acquired Pneumonia and Aspergillosis
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-11-17
45
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to study the immune and pathological features of patients with severe community-acquired pneumonia CAP admitted to the intensive care unit ICU, comparing those with influenza infection to those without. The study also seeks to link these findings to the occurrence of secondary invasive pulmonary aspergillosis, a serious lung infection. Participants include adults aged 18 or older admitted to the ICU with respiratory distress caused by either influenza-positive or influenza-negative CAP. Patients are grouped into two categories those with microbiologically confirmed influenza-related CAP and those with CAP but no influenza infection. The study will observe and compare immune cell profiles, cytokine responses, and neutrophil function in both blood and bronchoalveolar lavage BAL fluid samples from these patients. The research will continue through three influenza seasons, spanning approximately three years. Participants will undergo assessments of blood and BAL fluid to analyze immune responses and pathological markers related to their lung condition. The study will track changes over time and correlate them with the development of invasive pulmonary aspergillosis and patient outcomes. This observational study involves no investigational treatments but focuses on detailed monitoring and data collection during the ICU stay and follow-up periods.
CONDITIONS
Brief Title
Influenza Associated Aspergillosis In-depth Investigation
Research Team
J
Joost Wauters, PhD
L
Lore Vanderbeke, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here